AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹32,595 Cr | ₹29,784 Cr | ₹26,781 Cr | ₹24,517 Cr | ₹21,871 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of AUROBINDO PHARMA ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2025 | ₹32,595 Cr |
| Mar2024 | ₹29,784 Cr |
| Mar2023 | ₹26,781 Cr |
| Mar2022 | ₹24,517 Cr |
| Mar2021 | ₹21,871 Cr |
How is Reserve excluding Revaluation Reserve of AUROBINDO PHARMA Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2025 | ₹32,595 Cr | 9.44 | |
| Mar2024 | ₹29,784 Cr | 11.21 | |
| Mar2023 | ₹26,781 Cr | 9.23 | |
| Mar2022 | ₹24,517 Cr | 12.10 | |
| Mar2021 | ₹21,871 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹69,608.9 Cr | -0.7% | 2.3% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.7% |
2.3% |
-6.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses